
1. mediators inflamm. 2016;2016:4158698. epub 2016 nov 15.

association heme oxygenase 1 lung protection malaria-associated
ali/ards.

pereira ml(1), ortolan ls(1), sercundes mk(2), debone d(2), murillo o(3), lima
fa(3), marinho cr(3), epiphanio s(2).

author information: 
(1)departamento de imunologia, instituto de ciências biomédicas, universidade de 
são paulo, são paulo, sp, brazil.
(2)departamento de análises clínicas e toxicológicas, faculdade de ciências
farmacêuticas, universidade de são paulo, são paulo, sp, brazil.
(3)departamento de parasitologia, instituto de ciências biomédicas, universidade 
de são paulo, são paulo, sp, brazil.

malaria serious disease, caused parasite genus plasmodium,
which responsible 440,000 deaths 2015. acute lung injury/acute
respiratory distress syndrome (ali/ards) one main clinical
complications severe malaria. murine model dba/2 reproduces clinical
signs ali/ards humans, infected plasmodium berghei anka. high
levels ho-1 reported cases severe malaria. data indicated 
the ho-1 mrna protein expression increased mice develop
malaria-associated ali/ards (ma-ali/ards). additionally, hemin, ho-1
inducing drug, prevented mice developing ma-ali/ards administered prior
to development ma-ali/ards model. also, hemin treatment showed 
amelioration respiratory parameters mice, high vegf levels sera, and
a decrease vascular permeability lung, signs ali/ards.
therefore, induction ho-1 development ma-ali/ards could be
protective. however, increased expression ho-1 onset ma-ali/ards
development may represent effort revert phenotype syndrome by
the host. therefore confirm ho-1 inducing drugs could used for
prevention ma-ali/ards humans.

doi: 10.1155/2016/4158698 
pmcid: pmc5126464
pmid: 27974865  [indexed medline]

conflict interest statement: authors declare commercial 
or associations might pose competing interests.

